Invention Grant
- Patent Title: Methods for diagnosis of and predicting treatment efficacy of hormone receptor expressing tumors, cancers and neoplasias
-
Application No.: US12975058Application Date: 2010-12-21
-
Publication No.: US10093961B2Publication Date: 2018-10-09
- Inventor: Carola Leuschner , Hector Alila
- Applicant: Carola Leuschner , Hector Alila
- Applicant Address: US LA Baton Rouge
- Assignee: ESPERANCE PHARMACEUTICALS
- Current Assignee: ESPERANCE PHARMACEUTICALS
- Current Assignee Address: US LA Baton Rouge
- Agency: Pillsbury Winthrop Shaw Pittmann LLP
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; G01N33/53 ; G01N33/566 ; G01N33/574

Abstract:
The invention relates to diagnosis, detection, screening, identifying and predicting methods. In various embodiments, methods of the invention include diagnosis, detection, or screening for a hyperproliferative disorder (e.g., a tumor, cancer or neoplasia) in the subject; identifying a subject that will or is likely to respond to a therapy for a hyperproliferative disorder (e.g., a tumor, cancer or neoplasia); and predicting therapeutic efficacy of a hyperproliferative disorder (e.g., a tumor, cancer or neoplasia) treatment in a subject.
Public/Granted literature
Information query